Adar1 Capital Management, LLC Portfolio Holdings

Adar1 Capital Management, LLC

  • $652 Billion
  • Q2 2025

Adar1 Capital Management, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $652 Billion distributed in 210 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Keros Therapeutics, Inc. with a value of $71.9B, Protagonist Therapeutics, Inc with a value of $52.4B, Ea Series Trust with a value of $38B, Zai Lab LTD with a value of $29.7B, and Abivax Sa with a value of $23.5B.

Examining the 13F form we can see an increase of $113B in the current position value, from $539B to 652B.

Adar1 Capital Management, LLC is based out at Austin, TX

Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $652 Billion
Healthcare: $418 Billion
ETFs: $56.4 Billion
Basic Materials: $135 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
Colombier Acquisition Corp I
-
$155 Million 0.02% of portfolio
-
Q2 2025 Reduced 45.98%
Biomx Inc
-
$135 Million 0.02% of portfolio
-
Q1 2025 New
$186M
$108 Million 0.02% of portfolio
18,643
Q1 2025 Added 3.57%
$161M
$149 Million 0.02% of portfolio
37,161
Q2 2025 Reduced 57.67%
$397M
$137 Million 0.02% of portfolio
10,000
Q2 2025 New
$970M
$135 Million 0.02% of portfolio
48,300
Q2 2025 Added 70.67%
$109M
$148 Million 0.02% of portfolio
119,320
Q1 2025 Added 147.94%
Alumis Inc
-
$113 Million 0.02% of portfolio
-
Q2 2025 New
$712M
$150 Million 0.02% of portfolio
16,221
Q4 2024 New
$292M
$113 Million 0.02% of portfolio
10,000
Q2 2025 Reduced 72.02%
Engene Holdings Inc
-
$101 Million 0.02% of portfolio
-
Q2 2025 Added 16.76%
$9.63B
$135 Million 0.02% of portfolio
10,000
Q2 2025 New
$311M
$106 Million 0.02% of portfolio
28,415
Q2 2025 New
Procap Acquisition Corp
-
$114 Million 0.02% of portfolio
-
Q2 2025 New
$336M
$143 Million 0.02% of portfolio
42,408
Q2 2025 New
$63M
$107 Million 0.02% of portfolio
101,008
Q3 2024 Added 102.02%
A Spac Iii Acquisition Corp
-
$36.6 Million 0.01% of portfolio
-
Q1 2025 New
$94.6M
$58 Million 0.01% of portfolio
50,000
Q2 2025 New
Achieve Life Sciences Inc
-
$97.6 Million 0.01% of portfolio
-
Q1 2025 Added 227.74%
Aa Mission Acquisition Corp
-
$49.7 Million 0.01% of portfolio
-
Q3 2024 New
$1.6B
$84.7 Million 0.01% of portfolio
10,000
Q2 2025 New
$24.3M
$67.5 Million 0.01% of portfolio
170,506
Q2 2025 New
$873M
$93.7 Million 0.01% of portfolio
10,000
Q2 2025 New
Casi Pharmaceuticals Inc
-
$52.1 Million 0.01% of portfolio
-
Q2 2025 Reduced 6.96%
$162M
$54.3 Million 0.01% of portfolio
118,012
Q2 2025 Reduced 1.67%
$2.8B
$96.8 Million 0.01% of portfolio
10,000
Q1 2025 Reduced 75.12%
Ibio Inc
-
$41.8 Million 0.01% of portfolio
-
Q2 2025 New
$74M
$95.3 Million 0.01% of portfolio
82,189
Q2 2025 New
$9.26M
$85 Million 0.01% of portfolio
50,000
Q2 2025 New
$76.1M
$78 Million 0.01% of portfolio
130,000
Q2 2025 New
$229M
$96.6 Million 0.01% of portfolio
10,400
Q2 2025 New
$39.1M
$45.8 Million 0.01% of portfolio
16,900
Q2 2025 Added 1.81%
$100M
$81.5 Million 0.01% of portfolio
102,948
Q2 2025 Added 0.78%
$361M
$65 Million 0.01% of portfolio
25,000
Q2 2025 New
$120M
$38.2 Million 0.01% of portfolio
115,867
Q1 2025 Reduced 11.23%
$170M
$20.4 Million 0.0% of portfolio
10,000
Q2 2025 Reduced 50.97%
Keen Vision Acquisition Corp
-
$4.05 Million 0.0% of portfolio
-
Q2 2025 New
$11.3M
$21.3 Million 0.0% of portfolio
12,406
Q2 2025 New
Jvspac Acquisition Corp
-
$20.9 Million 0.0% of portfolio
-
Q2 2025 Reduced 20.0%
Movano Inc
-
$13 Million 0.0% of portfolio
-
Q4 2024 Reduced 98.35%
Mural Oncology Pub LTD CO
-
$29.3 Million 0.0% of portfolio
-
Q2 2025 New
$129M
$7.58 Million 0.0% of portfolio
10,366
Q2 2025 New
Iron Horse Acquisitions Corp
-
$6.14 Million 0.0% of portfolio
-
Q2 2025 Reduced 50.72%
Onkure Therapeutics Inc
-
$23.9 Million 0.0% of portfolio
-
Q1 2025 New
Embrace Change Acquisitn Cor
-
$1.5 Million 0.0% of portfolio
-
Q3 2024 Reduced 26.98%
Leap Therapeutics Inc
-
$11.9 Million 0.0% of portfolio
-
Q2 2025 Reduced 64.03%
$121M
$22.6 Million 0.0% of portfolio
20,352
Q1 2025 New
Embrace Change Acquisitn Cor
-
$360,000 0.0% of portfolio
-
Q4 2023 New
$81.4M
$10.1 Million 0.0% of portfolio
10,300
Q1 2025 New

Summary

  • Portfolio
  • No. of Stocks 210
  • Current Value $652 Billion
  • Prior Value $539 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 43 stocks
  • Additional Purchases 61 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 53 stocks
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email